Molecules 2019, 24, 4184
7 of 10
Julia–Kocienski olefination
The phenyltetrazole sulfone derivative (1 equiv) was dissolved/diluted in THF (0.15 M) and
cooled to
78 ◦C. A freshly prepared LiHMDS solution in THF (1.5 equiv) was added slowly and
stirred for a further 30 min at
78 ◦C. Aldehyde (2 equiv) was added neat and stirred for a further
3 h at
78 ◦C. The reaction mixture was allowed to reach rt and was further stirred at rt overnight.
H2O and Et2O were added to the reaction suspension, and the layers were separated. The aqueous
phase was extracted with Et2O (3 ). The combined organic layers were washed with brine and dried
−
−
−
×
over Na2SO4. The solvent was removed under reduced pressure, and the crude product was purified
by FC.
5-((2-(1-Azidocyclohexyl)ethyl)sulfonyl)-1-phenyl-1H-tetrazole (15a)
According to the procedure A from di-tert-butylhyponitrite (17 mg, 0.10 mmol),
methylenecyclohexane 5a (0.24 mL, 2.00 mmol), 5-((iodomethyl)sulfonyl)-1-phenyl-1H-tetrazole 14
(350 mg, 1.00 mmol), hexabutylditin (0.61 mL, 1.20 mmol), and 3-PySO2N3 (552 mg, 3.00 mmol) in
benzene (2.0 mL). The crude mixture was directly purified by FC using KF/silica gel (cyclohexane/EtOAc,
95:5) to afford 15a (325 mg, 90%).
According to the procedure B from a 1 M solution of Et3B in CH2Cl2 (4.00 mL, 4.00 mmol),
methylenecyclohexane 5a (0.24 mL, 2.00 mmol), 5-((iodomethyl)sulfonyl)-1-phenyl-1H-tetrazole 14
,
(350 mg, 1.00 mmol), 3-PySO2N3 (552 mg, 3.00 mmol), and CH2Cl2 (0.50 mL). Purification by FC
(cyclohexane/EtOAc, 95:5) afforded 15a (260 mg, 72%). The NMR spectra of some compounds are in
the Supplementary Materials.
Colorless crystals: m.p. 90.9–93.6 ◦C. 1H NMR (300 MHz, CDCl3):
3H), 3.90–3.84 (m, 2H), 2.24–2.18 (m, 2H), 1.81–1.73 (m, 2H), 1.69–1.29 (m, 8H). 13C NMR (75 MHz,
δ = 7.76–7.72 (m, 2H), 7.69–7.62 (m,
CDCl3):
δ = 153.31, 132.96, 131.50, 129.75 (2C), 125.00 (2C), 62.45, 51.61, 34.41 (2C), 31.72, 25.07, 21.96
(2C). IR (neat): 2933, 2856, 2098, 1497, 1337, 1253, 1150. HRMS (ESI): calcd. for [M + H]+: C15H20N7O2S
calcd 362.1394; found: 362.1400.
(3-(1-Azidocyclohexyl)prop-1-en-1-yl)benzene (17a)
According to the Julia–Kocienski procedure from 15a (260 mg, 0.72 mmol), LiHMDS in THF
(1.66 mL, 1.08 mmol), benzaldehyde (0.15 mL, 1.44 mmol), and THF (3.00 mL). Purification by FC
(cyclohexane/EtOAc, 98:2) afforded the alkene 17a as an inseparable mixture of isomers (141 mg, E/Z >
95:5, 81%). Colorless oil.
1
(E)-17a (major): H NMR (300 MHz, CDCl3):
δ = 7.39–7.20 (m, 5H), 6.47 (d, J = 15.8 Hz, 1H), 6.24 (dt,
J = 15.8, 7.4 Hz, 1H), 2.46 (dd, J = 7.4, 1.2 Hz, 2H), 1.72 (d, J = 13.1 Hz, 2H), 1.65–1.39 (m, 7H), 1.32–1.21
(m, 1H). 13C NMR (75 MHz, CDCl3): = 137.24, 133.74, 128.51 (2C), 127.29, 126.17 (2C), 124.36, 64.22,
43.93, 34.52 (2C), 25.33, 22.07 (2C).
1
Characteristic signals for (Z)-17a (minor): H NMR (300 MHz, CDCl3):
δ = 2.55 (d, J = 5.8 Hz, 2H). IR
(neat): 3027, 2931, 2858, 2096, 1495, 1447, 1254, 1138, 1102, 1029. EI-MS m/z (%): M–N2: 213.3 (21),
198.3 (7), 170.3 (20), 156.3 (16), 128.3 (10), 117.3 (100), 115.3 (73), 96.3 (63), 91.3 (40), 69.3 (34), 55.3 (39).
HRMS (ESI): calcd. for [M + H]+: C15H20N3: 242.1652; found: 242.1655.
4. Conclusions
In conclusion, we demonstrated that the azidoalkylation of terminal alkenes is not limited to
α
-iodoester and α-iodoketones. The reaction also works well with nitriles, phosphonates, phthalimides,
and aryl sulfones. This last class of compounds is particularly interesting in terms of potential synthetic
applications. This point was illustrated by the preparation of homoallylic azides by merging the
azidoalkylation process with a Julia–Kocienski olefination reaction. Recently, 1-phenyl-1H-tetrazole
sulfones have also been shown to be privileged substrates for reductive cross-coupling processes,
opening new opportunities for further functionalization [51,52].